Multiomics to elucidate inflammatory bowel disease risk factors and pathways

M Agrawal, KH Allin, F Petralia, JF Colombel… - Nature reviews …, 2022 - nature.com
Inflammatory bowel disease (IBD) is an immune-mediated disease of the intestinal tract, with
complex pathophysiology involving genetic, environmental, microbiome, immunological and …

[HTML][HTML] Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease

K Hodgkinson, F El Abbar, P Dobranowski… - Clinical Nutrition, 2023 - Elsevier
Butyrate is a key energy source for colonocytes and is produced by the gut microbiota
through fermentation of dietary fiber. Butyrate is a histone deacetylase inhibitor and also …

Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity

RH Mills, PS Dulai, Y Vázquez-Baeza, C Sauceda… - Nature …, 2022 - nature.com
Ulcerative colitis (UC) is driven by disruptions in host–microbiota homoeostasis, but current
treatments exclusively target host inflammatory pathways. To understand how host …

Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer

C Kong, L Liang, G Liu, L Du, Y Yang, J Liu, D Shi, X Li… - Gut, 2023 - gut.bmj.com
Objective The incidence of early-onset colorectal cancer (EO-CRC) is steadily increasing.
Here, we aimed to characterise the interactions between gut microbiome, metabolites and …

Mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation

W Turpin, M Dong, G Sasson, JAR Garay… - Gastroenterology, 2022 - Elsevier
Background & Aims Case-control studies have shown that patients with Crohn's disease
(CD) have a microbial composition different from healthy individuals. Although the causes of …

Implications of the changing epidemiology of inflammatory bowel disease in a changing world

M Agrawal, T Jess - United European gastroenterology journal, 2022 - Wiley Online Library
The epidemiology of inflammatory bowel disease (IBD) has undergone considerable shifts
since its emergence in the Western world over a century ago, especially in the last few …

[HTML][HTML] Disease monitoring in inflammatory bowel disease: evolving principles and possibilities

N Plevris, CW Lees - Gastroenterology, 2022 - Elsevier
Inflammatory bowel disease is a progressive and debilitating condition. Early and effective
treatment utilizing a treat to target approach is key in improving patient outcomes. Therefore …

Recipient factors in faecal microbiota transplantation: one stool does not fit all

C Danne, N Rolhion, H Sokol - Nature Reviews Gastroenterology & …, 2021 - nature.com
Faecal microbiota transplantation (FMT) is a promising therapy for chronic diseases
associated with gut microbiota alterations. FMT cures 90% of recurrent Clostridioides difficile …

Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease

H Leibovitzh, SH Lee, M Xue, JAR Garay… - Gastroenterology, 2022 - Elsevier
Background & Aims The gut microbiome has been suggested to play a role in gut barrier
hemostasis, but data are scarce and limited to animal studies. We therefore aimed to assess …

Location-specific signatures of Crohn's disease at a multi-omics scale

CG Gonzalez, RH Mills, Q Zhu, C Sauceda, R Knight… - Microbiome, 2022 - Springer
Background Crohn's disease (CD), an inflammatory bowel disease (IBD) subtype, results
from pathologic interactions between host cells and its resident gut microbes. CD manifests …